Synthetic biology company EnginZyme, recently announced that it has raised €6.4mn in Series A investment led by Sofinnova Partners. With the new investment, the company’s total funding stands over €10mn. The company plans to use these funds to accelerate the development of EnginZyme’s technology platform and take its first internal production process to pilot. The…